As reported by Brian Gormley in Wall Street Journal (found here):

Doctors and researchers in Hong Kong are betting an artificial intelligence-based remote-monitoring system from startup Biofourmis Inc. will aid them in their fight against disease caused by a new coronavirus. Startups are deploying AI in various ways to battle the new coronavirus, which has infected more than 90,000 people globally, according to data compiled by Johns Hopkins University.

Boston-based Biofourmis uses a biosensor to gather biological information from patients and AI-based analytics to spot changes in their health, such as a worsening of their condition. Medical professionals can remotely monitor patients and intervene when necessary. Biofourmis said its system will be used by a remote-monitoring and disease-surveillance program in Hong Kong designed to help people who have been infected with coronavirus and improve understanding of the illness it causes.The program administered by the University of Hong Kong will use the company’s system on people quarantined because of a suspected coronavirus infection and on patients hospitalized with confirmed cases.

The startup’s biosensor is worn on an arm and detects parameters such as temperature and heart and respiration rates. It can be used on quarantined people to pick up on early signs and symptoms of disease, Chief Executive Kuldeep Singh Rajput said. Biofourmis aims to get 500 to 1,000 quarantined people in Hong Kong onto its system in the next two to three weeks, he said. The system includes a smartphone app that asks patients questions about symptoms. Physicians use a web dashboard to observe patients and can be alerted to significant changes or problems, according to Biofourmis. Data collected by Biofourmis can be combined with other types of data such as imaging and lab tests to help doctors and researchers learn more about coronavirus and how to treat people who have fallen ill, according to Mr. Rajput.

In the U.S., the company’s technology could likewise help health-care professionals manage coronavirus-infected patients or people quarantined because of suspected infections, he said. The Centers for Disease Control and Prevention recently recommended health-care providers seeking to limit the spread of coronavirus increase telephone and other remote methods of managing patients to decrease the volume of people coming to medical centers.

In addition to its work in Hong Kong and its efforts in telemedicine, Biofourmis sees an opportunity for its AI system to help drugmakers understand the new coronavirus and determine how effective their treatments are against it, Mr. Rajput said.

Biofourmis has raised about $45 million in venture capital from Sequoia India, MassMutual Ventures and Openspace Ventures.